Navigation Links
Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System
Date:9/29/2008

New VBR is designed to offer a less invasive surgical approach to the

thoracolumbar spine

MARQUETTE, Mich., Sept. 29 /PRNewswire/ -- Pioneer Surgical Technology, Inc. announced today the market release of the Cross-Fuse(TM) Lateral Option System. The Cross-Fuse is Pioneer's latest addition to a comprehensive family of PEEK (poly-ether-ether-ketone) VBRs.

Dr. Richard Nussbaum of the Los Angeles Orthopaedic Institute in Sherman Oaks, California says, "The Cross-Fuse provides surgeons the option of performing a lateral procedure for fusing the spine which is less disrupting to back muscles, ligaments and major vessels in posterior spinal surgery. The use of Cross-Fuse in conjunction with percutaneous fixation results in improved patient outcomes." According to Nussbaum, "By combining an easy to use implant system with a lateral approach procedure, it's likely we'll see reduced Operating Room times." The Cross-Fuse System is designed to restore the biomechanical integrity of the thoracolumbar spine.

"The entire Cross-Fuse system, from implants to instrumentation, is well thought out," according to Dr. Thomas Highland of the Columbia Orthopaedic Group, Columbia, Missouri. Highland states, "The innovative design of the trial spacers and other instruments are very user-friendly, and the PEEK material in the Cross-Fuse implants causes no artifact in MRI or CT imaging."

The Cross-Fuse system is designed to be used with Pioneer's Quantum(R) Spinal Rodding System and the Clarity(TM) Lateral Retractor System.

About Pioneer Surgical Technology

Pioneer Surgical Technology, Inc., headquartered in Marquette, Michigan, is a dynamic medical device firm with a full line of cutting-edge motion preservation devices, either available commercially in Europe or under clinical evaluation in the U.S. Pioneer's signature articulating P3(TM) Technology - Pioneer PEEK-on-PEEK, in its NuBac(TM) disc arthroplasty system, BacJac(TM) interspinous decompression system, and NuNec(TM) artificial cervical disc, is the most technologically advanced in the industry. In addition, Pioneer's reputable portfolio of spinal fusion products includes novel vertebral spacers, industry-leading cervical plating systems, and comprehensive MIS and Mini-Open systems. Thoughtful innovation has rewarded Pioneer with over 100 U.S. and Foreign patents with numerous patents pending. The company established a Biologics Division following two acquisitions in 2007. Pioneer Orthobiologics is developing a rich pipeline of products indicated for a variety of spinal and orthopaedic applications. Pioneer focuses on developing novel products which are easier and faster for the surgeon, cost effective for the health care system, and provide better patient outcomes.


'/>"/>
SOURCE Pioneer Surgical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pioneer(R) Surgical Technology Introduces the BacJac(TM) Interspinous Decompression System to the European Spine Market
2. Pioneer(R) Surgical Technology, Inc. Continues to Prove Science Behind PEEK-on-PEEK(TM) Technology for Motion Preservation Devices
3. An analysis of the surgical and perioperative complications in right hepatectomies
4. Surgical technique halts cell loss, Parkinsons researchers find
5. Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles
6. Older Adults Reluctant to Question Surgical Treatment
7. Study shows that surgical weight loss does not eliminate obstructive sleep apnea
8. Specialty Surgery Center to Partner With Surgical Care Affiliates
9. STAAR Surgical to Present at the Noble Financial Equity Conference
10. Leading Neurosurgical Center in Moscow Purchases CyberKnife System to Expand Ability to Treat Brain and Spinal Tumors
11. New Steril-Eze Surgical Case Carts from Eagle MHC Feature Rugged, Easy-Clean Design
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with ... every IT system, from the datacenter to the cloud to the edge. Through ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: